Detalhe da pesquisa
1.
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
Clin Infect Dis
; 77(7): 950-960, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338118
2.
Management of systemic sclerosis: British Society for Rheumatology guideline scope.
Rheumatol Adv Pract
; 7(1): rkad022, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923262